Sinomenine alleviates diabetic peripheral neuropathic pain through inhibition of the inositol‐requiring enzyme 1 alpha–X‐box binding protein 1 pathway by downregulating prostaglandin‐endoperoxide synthase 2
Journal of Diabetes Investigation · 2023-03 · 14 (3) · 364-375
DOI: 10.1111/jdi.13938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 24.01.2023. Verfasst von Ji Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First People's Hospital of Huaihua, Huaihua, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Neuropathies, Neuralgia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Excellent Youth Foundation of Hunan Provincial Department of Education, Natural Science Foundation of Hunan Province, Project of Hunan Provincial Health Commission.
Abstract (Originalsprache)
Introduction
We tried to show the effect of sinomenine (SIN) in diabetic peripheral neuropathic pain (DPNP) and the related underlying mechanism.
Methods
Network pharmacological analysis and bioinformatics analysis were carried out for identification of the active ingredients of Sinomenium acutum and the related genes. The DPNP rat model was constructed and primary rat spinal cord microglial cells were isolated for in vitro cell experiments. The therapeutic role of SIN in DPNP was determined in vivo and in vitro through analysis of microglial cell activation and inflammatory response.
Results
Therapeutic role of S. acutum in DPNP was mainly achieved by regulating 14 key genes, among which the target gene prostaglandin‐endoperoxide synthase 2 ( PTGS2 ) of SIN might be the key gene . An in vivo experiment showed that SIN inactivated the inositol‐requiring enzyme 1 alpha–X‐box binding protein 1 pathway by downregulating PTGS2 , which relieved pain symptoms in DPNP rats. It was confirmed in vivo that SIN inhibited the pathway through PTGS2 to alleviate the activation of spinal cord microglial cells and inflammatory response .
Conclusion
SIN decreases the expression of PTGS2 to inactivate the inositol‐requiring enzyme 1 alpha–X‐box binding protein 1 signaling pathway, which inhibits microglial activation, as well as the release of inflammatory factors, thus alleviating DPNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The First People's Hospital of Huaihua, Huaihua, China.
- Department of Anesthesiology, The First People's Hospital of Huaihua, Huaihua, China.
- Department of Anesthesiology, Hengyang Medical School, The First Affiliated Hospital, University of South China, Hengyang, China.
ORCID-Profile: Fengrui Yang
Förderung
- Excellent Youth Foundation of Hunan Provincial Department of Education
- Natural Science Foundation of Hunan Province
- Project of Hunan Provincial Health Commission
Zitieren
APA
Chen, J., Guo, P., Liu, X., Liao, H., Chen, K., Wang, Y., Qin, J., & Yang, F. (2023). Sinomenine alleviates diabetic peripheral neuropathic pain through inhibition of the inositol‐requiring enzyme 1 alpha–X‐box binding protein 1 pathway by downregulating prostaglandin‐endoperoxide synthase 2. Journal of Diabetes Investigation, 14(3), 364-375. https://doi.org/10.1111/jdi.13938
Vancouver
Chen J, Guo P, Liu X, Liao H, Chen K, Wang Y, et al. Sinomenine alleviates diabetic peripheral neuropathic pain through inhibition of the inositol‐requiring enzyme 1 alpha–X‐box binding protein 1 pathway by downregulating prostaglandin‐endoperoxide synthase 2. Journal of Diabetes Investigation. 2023;14(3):364-375. doi:10.1111/jdi.13938
BibTeX
@article{Chen2023,
author = {Chen, Ji and Guo, Peng and Liu, Xinxin and Liao, Huizhi and Chen, Kemin and Wang, Yuxia and Qin, Jie and Yang, Fengrui},
title = {Sinomenine alleviates diabetic peripheral neuropathic pain through inhibition of the inositol‐requiring enzyme 1 alpha–X‐box binding protein 1 pathway by downregulating prostaglandin‐endoperoxide synthase 2},
journal = {Journal of Diabetes Investigation},
year = {2023},
volume = {14},
number = {3},
pages = {364--375},
doi = {10.1111/jdi.13938}
}
EUVIMED